Bausch Health
BHC
#3591
Rank
A$4.62 B
Marketcap
$12.55
Share price
-0.12%
Change (1 day)
19.13%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : A$32.99 Billion

According to Bausch Health 's latest financial reports the company's total debt is A$32.99 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31A$32.86 B7.68%
2022-12-31A$30.51 B-2.34%
2021-12-31A$31.24 B0.43%
2020-12-31A$31.11 B-15.87%
2019-12-31A$36.98 B7.2%
2018-12-31A$34.50 B5.86%
2017-12-31A$32.59 B-21.29%
2016-12-31A$41.40 B-3.02%
2015-12-31A$42.69 B129.36%
2014-12-31A$18.61 B-4.46%
2013-12-31A$19.48 B83.64%
2012-12-31A$10.61 B63.57%
2011-12-31A$6.48 B78.49%
2010-12-31A$3.63 B732.18%
2009-12-31A$0.43 B383.66%
2008-12-31A$90.28 M
2006-12-31A$0.52 B-12.77%
2005-12-31A$0.59 B-3.53%
2004-12-31A$0.61 B-43.38%
2003-12-31A$1.09 B-17.59%
2002-12-31A$1.32 B1366.56%
2001-12-31A$90.44 M-93.15%
2000-12-31A$1.32 B531.41%
1999-12-31A$0.20 B0.97%
1998-12-31A$0.20 B2655.6%
1997-12-31A$7.52 M-14.65%
1996-12-31A$8.81 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.41 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA